Suchita C.

Suchita C. is a globally recognized leader in pricing, reimbursement, and market access, boasting over 15 years of experience in the healthcare industry. They have held significant roles at prominent organizations, including GSK, Gilead Sciences, and Mereo BioPharma, where they focused on developing innovative asset strategies and ensuring launch excellence for rare disease assets. Suchita currently serves as Project Co-chair for the ISPOR Emerging and Orphan Therapies Special Interest Group, continuously driving evidence-based solutions in the market. They obtained multiple degrees from the Indian Institute of Technology, Madras, reflecting a strong academic foundation in business and science.